Home / Intelligence / Case Studies / Mapping Payer & Employer Perceptions of Novel Migraine Therapies to Support Access Strategy Development
Trinity conducted a payer and employer advisory board to understand current perceptions of novel migraine therapies and potential strategies to improve access.
Geographic Scope: ![US Flag](https://trinitylifesciences.com/wp-content/uploads/2020/03/US-flag.png)
Client Situation
The client wanted to gather the payer and employer perspective on how the migraine landscape is evolving, and pressure test key strategic options as well as messages that they had developed. The employers included: Coca-Cola Company, Metro Nashville Public Schools, St. Louis Community College, and Vibra Healthcare.
Trinity’s Solution
Trinity conducted an unblinded advisory board with a diverse set of payers and employee benefit managers to understand current perceptions of the migraine landscape and the employer interaction with payers as it pertains to influencing employee access to novel migraine therapies.
Deliverables
- Moderator Guide targeting each advisory board stakeholder
- Pre-Survey and Workbook materials designed to capture individual data responses
- Two advisory board sessions where the client played an active role – including individual payer and employer breakout sessions
- Final Report and Executive Summary synthesizing live / written payer and employer insights, highlighting strategic opportunities, challenges, and recommendations
Project Outcomes & Impact
Bringing together both payers and employers into an ad board setting created a real-world dynamic that is not often simulated through market research activities. The feedback within the section on “Cross-Stakeholder Approaches to Engagement on Migraine” provided the client with clear insights on how to effectively engage both stakeholder groups, with a primary output being a tool that payers can use to educate their employer clients on costs associated with migraine and to inform them on how to mitigate costs for their organizations.
Related Intelligence
Webinars
Looking Ahead to the November Election and Beyond
August 14, 2024 | 1:00 – 2:00 PM ET
As healthcare policy and the access landscape evolve, biopharma companies face challenges in navigating this ever-changing space. To help organizations prepare for and adapt to these changes, Trinity Life Sciences is offering a new webinar series, The Next Era in U.S. Healthcare Policy & Access. Join us for the first webinar in the series, Looking Ahead […]
Sign Up Now
Blog
Developing Effective Global Value Dossiers
Trinity Life Sciences recently worked with a large global pharma company to develop a new process for creating global value dossiers (GVDs) that better met the needs of regional affiliates. Matt O’Hara, who leads Trinity’s Evidence Strategy practice, shares insights into the project with Mary Fletcher-Louis, who recently joined Trinity to head Trinity’s Value Center […]
Read More
Blog
Rise with the Waves: UK – Now and Beyond – Four Policy Trends That May Shape Pharma’s Future
Executive Summary The global payer landscape is rapidly evolving and is expected to continuously impact manufacturers’ decisions about new launches, portfolio management, trial design and importantly, pricing and market access strategy. In the UK, several policy reforms have been introduced which are expected to improve patient access while balancing financial healthcare sustainability and overall market […]
Read More